|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0015127,
umls-concept:C0027540,
umls-concept:C0086418,
umls-concept:C0087111,
umls-concept:C0205198,
umls-concept:C0205231,
umls-concept:C0205373,
umls-concept:C0522537,
umls-concept:C1314792,
umls-concept:C1517564
|
|
pubmed:issue |
2-3
|
|
pubmed:dateCreated |
1990-11-15
|
|
pubmed:abstractText |
Therapeutic effects were obtained after systemic treatment of athymic mice bearing an epidermoid non-small cell human lung carcinoma (NSCLC) xenograft with tricyclodecan-9-yl xanthogenate (D609) and the potassium salt of a fatty (dodecanoic) acid. Extensive intratumoral necrosis was observed 3 days after the treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0304-3835
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
97-102
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:2170004-Animals,
pubmed-meshheading:2170004-Antineoplastic Agents,
pubmed-meshheading:2170004-Bridged Compounds,
pubmed-meshheading:2170004-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:2170004-Drug Combinations,
pubmed-meshheading:2170004-Humans,
pubmed-meshheading:2170004-Lauric Acids,
pubmed-meshheading:2170004-Lung Neoplasms,
pubmed-meshheading:2170004-Mice,
pubmed-meshheading:2170004-Mice, Nude,
pubmed-meshheading:2170004-Necrosis,
pubmed-meshheading:2170004-Neoplasm Transplantation,
pubmed-meshheading:2170004-Thiones
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Systemic treatment of a human epidermoid non-small cell lung carcinoma xenograft with a xanthate compound causes extensive intratumoral necrosis.
|
|
pubmed:affiliation |
Institute for Virus Research, German Cancer Research Center, Heidelberg.
|
|
pubmed:publicationType |
Journal Article
|
